human
tcell
leukemia
viru
type
associ
diseas
poorli
treatabl
vaccin
avail
high
provir
load
one
major
risk
factor
diseas
develop
encod
tax
oncoprotein
activ
transcript
viral
long
termin
repeat
ltr
variou
type
cellular
promot
counteract
tax
function
might
prophylact
therapeut
benefit
work
report
suppress
tax
activ
ltr
deacetylas
transcript
activ
tax
ltr
larg
ablat
overexpress
tax
activ
nfb
unaffect
contrari
activ
ltr
tax
boost
deplet
treatment
cell
resveratrol
shunt
tax
activ
manner
activ
cell
resveratrol
potent
inhibit
provir
transcript
tax
express
wherea
compromis
specif
inhibitor
augment
mrna
express
administr
resveratrol
also
decreas
product
cellfre
virion
cell
transmiss
cell
uninfect
jurkat
cell
cocultur
associ
tax
cell
treatment
resveratrol
prevent
interact
tax
creb
recruit
creb
taxrespons
element
ltr
work
demonstr
neg
regulatori
function
tax
activ
transcript
smallmolecul
activ
resveratrol
might
consid
new
prophylact
therapeut
agent
diseas
human
tcell
leukemia
viru
type
caus
highli
lethal
blood
cancer
chronic
debilit
diseas
spinal
cord
treatment
unsatisfactori
vaccin
avail
diseas
progress
associ
robust
express
gene
suppress
gene
express
might
prevent
therapeut
benefit
therefor
critic
host
factor
control
gene
express
identifi
character
work
reveal
new
host
factor
suppress
gene
express
natur
compound
activ
suppress
find
provid
new
knowledg
host
control
gene
express
also
suggest
new
strategi
use
natur
compound
prevent
treatment
diseas
h
uman
tcell
leukemia
viru
type
infect
million
peopl
worldwid
caus
adult
tcell
leukemia
atl
infect
peopl
mani
year
latent
infect
develop
atl
highli
aggress
poorli
treatabl
also
caus
chronic
disabl
neurolog
disord
term
tropic
spastic
paraparesi
tsp
anoth
infect
popul
treatment
option
tsp
also
limit
wors
still
vaccin
prophylact
measur
prevent
atl
tsp
develop
carrier
avail
although
atl
tsp
develop
long
process
involv
multipl
viral
host
environment
factor
high
provir
load
singl
one
major
risk
factor
encod
viral
oncoprotein
tax
drive
initi
progress
atl
cellular
transcript
factor
creb
tax
potent
activ
long
termin
repeat
ltr
mani
cellular
protooncogen
immunoregulatori
gene
tax
also
interact
wide
varieti
cellular
protein
dysregul
cell
physiolog
signal
although
addit
viral
oncoprotein
hbz
addit
taxactiv
cellular
transcript
factor
nfb
also
contribut
differ
stage
atl
develop
tax
activ
creb
essenti
initi
malign
transform
thu
counteract
tax
creb
activ
might
antiatl
effect
least
infect
individu
activ
tax
stringent
control
viral
cellular
cofactor
previous
identifi
character
cellular
cofactor
tax
activ
creb
addit
crebbind
protein
cbp
crebregul
transcript
coactiv
crtc
altern
known
transduc
regul
creb
activ
torc
requir
tax
activ
ltr
addit
sever
cellular
protein
kinas
includ
kinas
liver
kinas
saltinduc
kinas
sik
influenti
process
view
essenti
regulatori
role
sik
tax
activ
creb
propos
metformin
pharmaceut
activ
sik
might
repurpos
prevent
treatment
atl
tsp
beststudi
mammalian
homolog
yeast
extend
life
span
prevent
genom
instabl
sirtuin
nad
depend
deacetylas
activ
histon
transcript
factor
transcript
regulatori
protein
reaction
revers
acetyl
catalyz
histon
transcript
factor
acetyltransferas
cbp
respons
metabol
signal
stress
posit
neg
regul
transcript
modifi
substrat
protein
addit
function
healthi
age
implic
metabol
stress
respons
cancer
diabet
human
immunodefici
viru
hiv
infect
deacetyl
transcript
factor
nfb
creb
well
transcript
coactiv
crtc
particularli
activ
creb
crtc
compromis
deacetyl
hand
transactiv
tat
interact
suppress
deacetyl
smallmolecul
activ
resveratrol
extens
test
prevent
treatment
diseas
clinic
trial
resveratrol
natur
compound
found
skin
red
grape
wide
sold
nutrit
supplement
oral
administr
resveratrol
mice
shown
extend
life
span
improv
health
surviv
howev
whether
resveratrol
might
affect
infect
transcript
remain
understood
studi
set
determin
influenc
tax
activ
ltr
provid
proof
concept
util
resveratrol
therapi
found
resveratrol
potent
suppress
transcript
find
support
model
suppress
tax
activ
ltr
imped
recruit
function
creb
crtc
work
also
implic
prevent
treatment
atl
tsp
cell
cultur
transfect
cell
grown
dulbecco
modifi
eagl
medium
jurkat
cell
propag
rpmi
medium
cell
transfect
use
genejuic
novagen
madison
wi
jurkat
cell
transfect
use
lipofectamin
invitrogen
grand
island
ny
plasmid
antibodi
reagent
luciferas
report
plasmid
pltrluc
pbluc
well
express
plasmid
tax
creb
detail
elsewher
tax
express
driven
cytomegaloviru
promot
sitedirect
mutagenesi
carri
describ
previous
rabbit
mous
mous
antiflag
purchas
sigmaaldrich
st
loui
mo
mous
invitrogen
rabbit
rabbit
mous
antibodi
glyceraldehyd
dehydrogenas
gapdh
santa
cruz
biotechnolog
dalla
tx
rabbit
antibodi
creb
acetyllysin
ack
cell
signal
danver
mous
antitax
describ
previous
resveratrol
sirtinol
bought
merck
whitehous
station
nj
milliporecalbiochem
danver
sigmaaldrich
respect
report
assay
protein
analysi
cell
harvest
h
transfect
dual
luciferas
assay
protein
analysi
perform
describ
previous
psvrluc
report
promega
madison
wi
use
intern
control
normal
transfect
effici
three
independ
experi
carri
standard
deviat
sd
calcul
twotail
student
test
perform
statist
assess
differ
desir
group
coimmunoprecipit
cell
harvest
immunoprecipit
buffer
mm
trishcl
ph
mm
nacl
mm
edta
mm
dithiothreitol
mm
mm
sodium
vanad
mm
phenylmethylsulfonyl
fluorid
precipit
protein
clear
cell
lysat
incub
mous
antiflag
sigmaaldrich
invitrogen
respect
h
antigenantibodi
complex
collect
protein
g
agaros
invitrogen
wash
three
time
immunoprecipit
buffer
resuspend
sampl
buffer
mm
triscl
sodium
dodecyl
sulfat
glycerol
bromophenol
blue
subsequ
sdspage
western
blot
analysi
immunoprecipit
endogen
tax
cell
jurkat
cell
grown
confluenc
harvest
ml
immunoprecipit
buffer
endogen
tax
protein
precipit
clear
lysat
incub
mous
antitax
chromatin
immunoprecipit
chromatin
immunoprecipit
carri
previous
describ
brief
cell
crosslink
formaldehyd
min
room
temperatur
cell
wash
cell
lysi
perform
presenc
proteas
inhibitor
cocktail
sonic
cell
debri
remov
centrifug
dnaprotein
complex
immunoprecipit
dna
extract
phenolchloroform
dna
sequenc
span
three
taxrespons
element
ltr
analyz
quantit
pcr
qpcr
primer
rna
interfer
cell
transfect
nm
small
interf
rna
sirna
use
lipofectamin
invitrogen
rna
interfer
experi
perform
describ
previous
sirna
sequenc
follow
sigfp
realtim
rtpcr
realtim
revers
transcriptionpcr
rtpcr
perform
essenti
describ
previous
primer
sequenc
tax
env
gapdh
transcript
also
describ
previous
total
rna
extract
perform
use
rnaiso
plu
reagent
takara
otsu
shiga
japan
cdna
synthesi
achiev
transcriptor
first
strand
cdna
synthesi
kit
roch
indianapoli
use
random
hexam
primer
realtim
pcr
perform
sybr
premix
ex
taq
reagent
takara
stepon
realtim
pcr
system
appli
biosystem
foster
citi
ca
normal
valu
sampl
deriv
rel
quantiti
target
mrna
divid
rel
quantiti
gapdh
mrna
rel
mrna
express
level
deriv
threshold
cycl
use
compar
c
method
quantit
virion
cell
seed
ml
overnight
cultur
medium
presenc
escal
amount
resveratrol
cultur
supernat
collect
ultracentrifug
h
g
supernat
jurkat
cell
use
neg
control
virus
resuspend
l
lysi
buffer
quantifi
use
colorimetr
revers
transcriptas
assay
kit
roch
describ
previous
measur
transmiss
cell
seed
ml
treat
resveratrol
h
jurkat
cell
seed
ml
transfect
pltrluc
prltk
h
treat
cell
transfect
jurkat
cell
mix
cocultur
extra
h
harvest
dual
luciferas
report
assay
acetyl
deacetyl
histon
transcript
factor
transcript
coregul
critic
involv
regul
transcript
smallmolecul
activ
deacetylas
extens
test
target
therapeut
cancer
thought
mind
sought
investig
might
affect
transcript
first
determin
effect
express
tax
activ
ltr
cell
increas
express
effect
blunt
tax
activ
ltr
basal
level
fig
compar
group
group
contrast
express
catalyt
inact
hy
mutant
previous
shown
deacetylas
defect
suppress
taxmedi
ltr
activ
observ
fig
compar
group
group
indic
requir
deacetylas
activ
suppress
tax
activ
ltr
also
known
target
substrat
mediat
nfb
activ
next
investig
whether
might
also
affect
tax
activ
nfb
surpris
express
hy
mutant
influenc
taxinduc
activ
nfb
fig
compar
group
group
word
exert
suppress
effect
specif
ltr
verifi
role
tax
activ
ltr
deplet
express
cell
use
two
independ
sirna
specif
silenc
effect
verifi
western
blot
fig
inset
silenc
augment
tax
activ
ltr
significantli
fig
compar
group
group
henc
function
neg
regul
transcript
resveratrol
inhibit
tax
activ
ltr
manner
implic
suppress
transcript
provid
new
opportun
ration
design
develop
agent
toward
end
test
effect
resveratrol
wellknown
activ
consist
observ
cell
treatment
cell
increas
amount
resveratrol
abrog
taxmedi
ltr
transactiv
progress
fig
compar
group
group
notabl
express
tax
protein
driven
cytomegaloviru
promot
remain
unchang
upon
administr
resveratrol
fig
inset
indic
suppress
effect
ltr
occur
primarili
step
subsequ
product
tax
line
lack
suppress
effect
tax
activ
nfb
fig
treatment
cell
resveratrol
affect
taxinduc
activ
nfb
activ
fig
compar
group
group
suppress
tax
activ
nfb
resveratrol
observ
high
concentr
fig
compar
group
group
might
attribut
nonspecif
effect
deplet
endogen
two
independ
sirna
suppress
effect
resveratrol
ltr
activ
complet
revers
fig
compar
group
group
henc
resveratrol
potent
suppress
taxmedi
ltr
transcript
manner
word
effect
resveratrol
tax
activ
ltr
mediat
primarili
addit
result
cell
similar
observ
concern
suppress
tax
activ
ltr
resveratrol
made
jurkat
cell
fig
compar
group
group
furthermor
ltr
activ
sever
compromis
cell
treat
resveratrol
fig
compar
group
group
group
group
data
consist
support
notion
resveratrol
repress
transcript
resveratrol
suppress
provir
transcript
virion
product
celltocel
transmiss
assess
effect
resveratrol
transcript
physiolog
context
treat
three
line
cell
ie
resveratrol
treatment
resveratrol
repress
ltrdriven
tax
env
mrna
express
ltrdepend
fluc
activ
normal
rluc
read
express
fold
activ
error
bar
indic
sd
triplic
experi
differ
group
group
statist
signific
twotail
student
test
p
valu
equal
indic
respect
b
lack
effect
tax
activ
nfb
cell
transfect
pbflucpsvrluc
report
plasmid
express
tax
wt
hy
statist
signific
differ
found
group
twotail
student
test
p
valu
equal
c
activ
ltr
knockdown
cell
transfect
sigfp
h
cell
cotransfect
pltrflucpsvrluc
report
tax
express
plasmid
addit
h
western
blot
perform
mous
differ
group
group
statist
signific
twotail
student
test
p
valu
equal
indic
respect
dosedepend
manner
three
line
detect
quantit
rtpcr
fig
b
line
express
tax
protein
also
diminish
resveratroltr
cell
fig
compar
lane
lane
decreas
tax
express
becam
promin
progress
increas
concentr
resveratrol
cell
fig
compar
lane
lane
lane
lane
addit
activ
highli
specif
smallmolecul
inhibitor
also
well
develop
valid
specif
effect
appli
two
differ
inhibitor
sirtinol
individu
cell
consist
earlier
result
pharmaceut
inhibit
augment
ltrdriven
product
tax
mrna
dosedepend
manner
fig
compar
group
group
group
group
similar
effect
sirtinol
tax
mrna
express
also
observ
cell
fig
compar
group
group
importantli
treatment
cell
resveratrol
perturb
product
cellfre
virion
dosedepend
manner
fig
compar
group
group
consist
resveratrol
block
transmiss
cell
uninfect
jurkat
cell
cocultur
fig
compar
group
group
collect
result
demonstr
effect
resveratrol
cell
acetyl
tax
influenc
ltr
activ
acetyl
tax
might
influenti
transform
potenti
activ
nfb
acetyl
deacetyl
tax
import
transcript
transform
interest
see
whether
deacetylas
might
affect
tax
acetyl
shed
light
immunoprecipit
tax
cell
express
hy
mutant
probe
precipit
antibodi
recogn
acetyllysin
steadyst
amount
acetyl
tax
decreas
presenc
increas
express
fig
compar
lane
lane
howev
chang
slight
investig
requir
elucid
whether
might
directli
deacetyl
tax
impact
tax
acetyl
ltr
activ
character
address
determin
whether
suppress
effect
resveratrol
tax
activ
ltr
might
mediat
deacetyl
tax
com
fig
differ
group
statist
signific
twotail
student
test
p
valu
equal
indic
effect
resveratrol
jurkat
cell
assay
perform
jurkat
cell
panel
differ
group
group
statist
signific
twotail
student
test
p
valu
equal
indic
indic
respect
e
effect
resveratrol
cell
cell
transfect
psvrluc
plu
either
group
pltrfluc
report
group
resveratrol
ad
cell
group
h
harvest
dual
luciferas
assay
perform
describ
legend
fig
differ
group
statist
signific
twotail
student
test
p
valu
equal
indic
pare
activ
tax
acetyl
mutant
ltr
activ
wherea
mimic
constitut
acetyl
state
nonacetylat
mutant
tax
mutant
equal
compet
activ
ltr
fig
compar
group
group
addit
three
form
suppress
similar
extent
resveratrol
fig
compar
group
group
group
group
thu
acetyl
tax
affect
ltr
activ
suppress
transcript
resveratrol
potent
suppress
effect
tax
activ
ltr
fig
suggest
tax
might
interact
explor
possibl
perform
coimmunoprecipit
cell
overexpress
tax
flagtag
presenc
tax
antiflag
precipit
obtain
cell
express
protein
fig
compar
lane
lane
indic
associ
two
entiti
cell
catalyt
inact
hy
mutant
retain
abil
associ
tax
albeit
lesser
extent
fig
compar
lane
lane
extend
analysi
endogen
protein
cell
similar
experi
also
done
cell
endogen
detect
antitax
precipit
obtain
extract
cell
fig
compar
lane
lane
band
precipit
less
promin
probabl
due
smaller
amount
tax
recov
fig
compar
lane
lane
nevertheless
result
demonstr
associ
tax
cell
resveratrol
prevent
taxcreb
interact
abovedescrib
result
knew
resveratrol
suppress
tax
activ
ltr
fig
differ
group
statist
signific
twotail
student
test
p
valu
equal
indic
f
effect
sirtinol
tax
mrna
express
cell
treat
indic
dose
sirtinol
h
rtqpcr
perform
panel
differ
group
statist
signific
twotail
student
test
p
valu
equal
indic
g
inhibit
virion
product
resveratrol
cell
treat
resveratrol
overnight
product
cellfre
virion
assess
measur
revers
transcriptas
activ
recov
live
cultur
supernat
colorimetr
assay
kit
roch
jurkat
cell
group
serv
neg
control
differ
group
statist
signific
twotail
student
test
p
valu
equal
indic
h
inhibit
celltocel
transmiss
resveratrol
cell
treat
either
dmso
resveratrol
h
jurkat
cell
transfect
pltrluc
prltk
h
treat
cell
transfect
jurkat
cell
mix
cocultur
addit
h
cell
harvest
dual
luciferas
report
assay
statist
analysi
perform
use
twotail
student
test
p
valu
equal
indic
addit
interact
tax
fig
tax
activ
ltr
primarili
interact
creb
ask
whether
resveratrol
might
perturb
interact
test
idea
coexpress
hy
mutant
togeth
tax
creb
cell
absenc
creb
associ
tax
fig
compar
lane
lane
interestingli
creb
detect
taxcontain
immunoprecipit
overexpress
fig
compar
lane
lane
howev
associ
tax
creb
remain
unaffect
cell
fig
compar
lane
lane
result
suggest
interfer
taxcreb
interact
activitydepend
manner
consist
addit
resveratrol
prevent
taxcreb
associ
even
lowest
dose
fig
compar
lane
lane
henc
resveratrol
block
interact
tax
creb
plausibl
perturb
function
tax
creb
transcript
resveratrol
perturb
creb
recruit
ltr
tax
activ
ltr
requir
creb
crtc
creb
master
regul
cell
metabol
bona
fide
oncoprotein
differ
context
variou
creb
regulatori
signal
converg
crtc
exert
effect
crtc
cooper
cbp
achiev
optim
activ
crebdepend
transcript
perturb
creb
crtc
signal
implic
malign
includ
associ
infect
epsteinbarr
viru
hepat
b
viru
interact
tax
fig
resveratrol
also
prevent
interact
tax
creb
fig
therefor
great
interest
see
whether
resveratrol
might
perturb
immunoprecipit
ip
perform
precipit
input
analyz
western
blot
mous
antiflag
antiacetyllysin
ack
band
immunoglobulin
heavi
chain
indic
ratio
acetyl
tax
versu
total
tax
actaxtax
determin
densitometri
indic
panel
b
influenc
tax
acetyl
ltr
activ
cell
transfect
pltrflucpsvrluc
report
express
plasmid
wildtyp
wt
acetyl
mutant
tax
cell
treat
indic
concentr
resveratrol
h
dual
luciferas
assay
perform
describ
legend
fig
statist
signific
differ
found
group
p
group
p
group
p
group
p
twotail
student
test
tax
activ
transcript
affect
recruit
creb
crtc
ltr
shed
light
mechan
resveratrol
counteract
tax
function
perform
chromatin
immunoprecipit
examin
rel
recruit
endogen
creb
ltr
creb
bound
ltr
cell
fig
b
c
compar
group
group
treat
cell
resveratrol
recruit
creb
ltr
compromis
fig
b
compar
group
group
fig
compar
group
group
data
suggest
resveratrol
repress
transcript
restrict
ltr
occup
creb
studi
obtain
first
evid
suppress
gene
express
first
demonstr
inhibit
tax
activ
ltr
nfb
went
show
repress
provir
gene
transcript
virion
product
celltocel
transmiss
resveratrol
smallmolecul
agonist
mechanist
interact
tax
prevent
tax
interact
creb
result
decreas
recruit
creb
ltr
work
reveal
interplay
tax
therebi
provid
new
regulatori
mechan
transcript
control
step
diseas
develop
find
resveratrol
may
also
guid
futur
develop
new
agent
prevent
intervent
atl
tsp
suppress
transcript
support
result
gainoffunct
lossoffunct
experi
conduct
cell
importantli
analysi
catalyt
dead
mutant
indic
requir
deacetylas
activ
suppress
transcript
deacetylasedead
mutant
still
interact
tax
lose
abil
imped
interact
tax
creb
suppress
tax
activ
ltr
thu
suppress
ltr
activ
deacetylas
activ
import
interact
tax
might
requir
suffici
perturb
taxcreb
interact
inhibit
recruit
creb
ltr
two
function
consequ
action
deacetylas
find
gener
consist
model
transcript
regul
h
cell
subject
chromatin
immunoprecipit
assay
creb
dna
complex
immunoprecipit
use
anticreb
b
c
taxrespons
sequenc
pcr
amplifi
rel
recruit
irrelev
igg
precipit
taken
basal
valu
panel
indic
p
valu
lane
p
valu
lane
panel
b
indic
p
valu
lane
p
valu
lane
panel
c
indic
p
valu
lane
provid
foundat
analysi
suppress
effect
transcript
transform
acetyl
tax
previous
shown
modul
nfb
activ
oncogen
transform
studi
clarifi
acetyl
tax
affect
ltr
activ
might
irrelev
suppress
effect
resveratrol
transcript
also
demonstr
influenc
tax
activ
nfb
suppress
effect
resveratrol
therefor
highli
specif
ltr
although
direct
deacetyl
tax
exclud
would
surpris
could
act
multipl
substrat
relev
tax
activ
transcript
thu
affect
deacetyl
function
histon
creb
crtc
transcript
regul
context
infect
merit
investig
particularli
intrigu
see
exactli
imped
interact
tax
creb
wherea
tax
play
major
role
initi
atl
tsp
express
subsid
later
stage
atl
develop
contrast
hbz
express
untransform
infect
cell
atl
fulli
develop
sinc
resveratrol
known
affect
hbz
express
use
resveratrol
might
feasibl
tax
express
high
carrier
tsp
patient
small
subset
atl
patient
resveratrol
alreadi
sold
nutrit
supplement
might
prove
use
mani
diseas
includ
variou
type
cancer
view
potenti
repurpos
resveratrol
atl
character
inhibitori
effect
tax
activ
transcript
virion
product
particularli
neg
impact
resveratrol
taxcreb
interact
ltr
occup
creb
document
analys
along
line
elucid
mechan
action
resveratrol
context
transcript
transform
detail
comparison
resveratrol
agent
interferon
alpha
zidovudin
use
clinic
atl
might
fulli
establish
util
resveratrol
atl
diseas
tsp
dose
resveratrol
use
studi
compar
lower
test
cellbas
model
one
recent
studi
vitro
benefici
effect
obtain
resveratrol
cultur
cell
found
highli
relev
mice
treat
moder
dose
mgkg
bodi
weight
per
day
resveratrol
toxic
effect
resveratrol
cultur
cell
observ
high
dose
administ
nevertheless
establish
physiolog
relev
vitro
result
mandatori
test
effect
resveratrol
primari
atl
cell
human
mous
model
infect
futur
analysi
activ
resveratrol
provid
proof
principl
activ
might
benefici
effect
atl
tsp
larg
panel
smallmolecul
activ
alreadi
test
clinic
trial
particularli
secondand
thirdgener
compound
avail
compar
resveratrol
synthet
activ
offer
greater
potenc
enhanc
solubl
improv
bioavail
agent
might
also
exhibit
potent
activ
sens
work
pave
way
develop
synthet
activ
novel
agent
treatment
atl
tsp
